Literature DB >> 18760181

Successful balloon-based radiofrequency ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report.

Roos E Pouw1, Joep J Gondrie, Wouter L Curvers, Carine M Sondermeijer, Fiebo J Ten Kate, Jacques J Bergman.   

Abstract

BACKGROUND: For selected patients with high-grade dysplasia (HGD) and/or early esophageal squamous cell cancer (ESCC), endoscopic therapy represents a nonsurgical treatment option. For widespread lesions, however, current endoscopic treatment modalities (eg, endoscopic resection, argon plasma coagulation, photodynamic therapy) are associated with considerable drawbacks, of which esophageal stricturing is the most significant. Balloon-based radiofrequency (RF) ablation (HALO System) is a promising technology for endoscopic treatment of Barrett's esophagus, and may also play a role in treating widespread HGD and early ESCC.
OBJECTIVE: We describe a case report of balloon-based RF ablation for HGD and early ESCC.
DESIGN: Case report.
SETTING: Tertiary care institution, Academic Medical Center, Amsterdam, The Netherlands. PATIENT: A 66-year-old male with a 35-mm large, flat-type ESCC with surrounding HGD. INTERVENTION: Balloon-based RF ablation (HALO System). MAIN OUTCOME MEASUREMENTS: Endoscopic and histological eradication of HGD and ESCC, and adverse events.
RESULTS: RF ablation resulted in complete endoscopic and histological eradication of HGD and ESCC without adverse events such as dysphagia or esophageal narrowing. LIMITATIONS: Single patient report, limited follow-up.
CONCLUSIONS: This is the first report of balloon-based RF ablation for esophageal HGD and early ESCC. The treatment resulted in complete eradication of a 35-mm flat ESCC with no adverse events. This suggests that this ablation technique deserves further study for the management of widespread HGD or flat-type ESCC.

Entities:  

Mesh:

Year:  2008        PMID: 18760181     DOI: 10.1016/j.gie.2008.03.1086

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  14 in total

1.  Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus.

Authors:  Jacques J G H M Bergman; Yue-Ming Zhang; Shun He; Bas Weusten; Liyan Xue; David E Fleischer; Ning Lu; Sanford M Dawsey; Gui-Qi Wang
Journal:  Gastrointest Endosc       Date:  2011-08-15       Impact factor: 9.427

Review 2.  Emerging indications of endoscopic radiofrequency ablation.

Authors:  Aymeric Becq; Marine Camus; Gabriel Rahmi; Vincent de Parades; Philippe Marteau; Xavier Dray
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

3.  Recurrent oesophageal intramucosal squamous carcinoma treated by endoscopic mucosal resection and subsequent radiofrequency ablation using HALO system.

Authors:  Ivana Kajzrlikova; Petr Vitek; Premysl Falt; Ondrej Urban; Pavel Kominek
Journal:  BMJ Case Rep       Date:  2010-12-20

Review 4.  The impact of flexible endoscopy in esophageal surgery.

Authors:  Alejandro Nieponice; Fabio Nachman; Adolfo Badaloni; Franco Ciotola; Cecilia Zubieta; Mauricio Ramirez
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

5.  Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation.

Authors:  Kumar Krishnan; John E Pandolfino; Peter J Kahrilas; Laurie Keefer; Lubomyr Boris; Srinadh Komanduri
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

6.  Radiofrequency ablation for early esophageal squamous cell neoplasia.

Authors:  Y M Zhang; J J G H M Bergman; B Weusten; S M Dawsey; D E Fleischer; N Lu; S He; G Q Wang
Journal:  Endoscopy       Date:  2010-03-16       Impact factor: 10.093

7.  A feasibility and dosimetric evaluation of endoscopic radiofrequency ablation for human colonic and rectal epithelium in a treat and resect trial.

Authors:  Joseph A Trunzo; Michael F McGee; Benjamin K Poulose; Joseph E Willis; Bridget Ermlich; Michelle Laughinghouse; Bradley J Champagne; Conor P Delaney; Jeffrey M Marks
Journal:  Surg Endosc       Date:  2010-07-22       Impact factor: 4.584

Review 8.  A systematic review of the evidence for radiofrequency ablation for Barrett's esophagus.

Authors:  Thomas Semlitsch; Klaus Jeitler; Rainer Schoefl; Karl Horvath; Nicole Pignitter; Franz Harnoncourt; Andrea Siebenhofer
Journal:  Surg Endosc       Date:  2010-05-13       Impact factor: 4.584

9.  Management of early-stage esophageal neoplasia (MESEN) consensus.

Authors:  Alejandro Nieponice; Adolfo E Badaloni; Blair A Jobe; Toshitaka Hoppo; Carlos Pellegrini; Vic Velanovich; Gary W Falk; Kevin Reavis; Lee Swanstrom; Virender K Sharma; Fabio Nachman; Franco F Ciotola; Luis E Caro; Cecilio Cerisoli; Demetrio Cavadas; Luis Durand Figueroa; Daniel Pirchi; Michael Gibson; Santiago Elizalde; Henry Cohen
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

Review 10.  Epidemiology of esophageal cancer.

Authors:  Yuwei Zhang
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.